Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kento Morozumi

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Hinyokika Kiyo. Acta Urologica Japonica|January 27, 2018
[Availability of Local Therapy to Castration-Resistant Prostate Cancer for M0 Patients with Initial Prostate Specific Antigen 100 ng/ml or Higher]Akito Kuromoto, Takaki Tanaka, Juntaro Koyama, et al.
IJU Case Reports|August 4, 2020
Familial testicular germ cell tumors in two brothersSenji Hoshi, Vladimir Bilim, Kiyotsugu Hoshi, et al.
The American Journal of Emergency Medicine|November 21, 2025
Head-to-head comparison of the CHOKAI and UROLITHIASIS scores for predicting ureteral stones: A multicenter prospective validationHiroki Fukuhara, Osamu Ichiyanagi, Asumi Sugiura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 15, 2025
Expression of Glucocorticoid Receptor Beta in Bladder Cancer and Its Clinicopathological Significance: A Novel Diagnostic Marker to Predict Progression and Recurrence of CancerTakashi Kukimoto, Yasuhiro Nakamura, Shuko Hata, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 18, 2022
Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8Kento Morozumi, Koji Mitsuzuka, Shintaro Narita, et al.
Hypertension (Dallas, Tex. : 1979)|March 6, 2026
Reliable Detection of SGLT2 Protein by Knockout-Based Antibody CharacterizationTakuo Hirose, Hiroki Ito, Akari Endo, et al.
Cancer Medicine|October 31, 2023
The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group databaseTomoyuki Koguchi, Sei Naito, Shingo Hatakeyama, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Hinyokika Kiyo. Acta Urologica Japonica|January 27, 2018
[Availability of Local Therapy to Castration-Resistant Prostate Cancer for M0 Patients with Initial Prostate Specific Antigen 100 ng/ml or Higher]Akito Kuromoto, Takaki Tanaka, Juntaro Koyama, et al.
IJU Case Reports|August 4, 2020
Familial testicular germ cell tumors in two brothersSenji Hoshi, Vladimir Bilim, Kiyotsugu Hoshi, et al.
The American Journal of Emergency Medicine|November 21, 2025
Head-to-head comparison of the CHOKAI and UROLITHIASIS scores for predicting ureteral stones: A multicenter prospective validationHiroki Fukuhara, Osamu Ichiyanagi, Asumi Sugiura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 15, 2025
Expression of Glucocorticoid Receptor Beta in Bladder Cancer and Its Clinicopathological Significance: A Novel Diagnostic Marker to Predict Progression and Recurrence of CancerTakashi Kukimoto, Yasuhiro Nakamura, Shuko Hata, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 18, 2022
Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8Kento Morozumi, Koji Mitsuzuka, Shintaro Narita, et al.
Hypertension (Dallas, Tex. : 1979)|March 6, 2026
Reliable Detection of SGLT2 Protein by Knockout-Based Antibody CharacterizationTakuo Hirose, Hiroki Ito, Akari Endo, et al.
Cancer Medicine|October 31, 2023
The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group databaseTomoyuki Koguchi, Sei Naito, Shingo Hatakeyama, et al.
Pageof 3